Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price fell 0.9% on Thursday . The stock traded as low as $3.36 and last traded at $3.42. 616,192 shares traded hands during mid-day trading, a decline of 12% from the average session volume of 700,769 shares. The stock had previously closed at $3.45.
Ono Pharmaceutical Trading Down 0.9 %
The stock’s fifty day moving average is $3.61 and its two-hundred day moving average is $4.25.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
